Ferrer Freeman’s most common sectors for investment are healthcare services (30%) and medical products (25%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (55%) and pipe (15%). In total, Ferrer Freeman has invested in 11 US states. Its largest (disclosed) acquisition occurred in 2007 when it acquired Reliant Renal Care for $50M.
In the last 3 years, Ferrer Freeman has exited 1 company. The Firm’s most common exit type is trade sale (73%). Ferrer Freeman’s largest (disclosed) exit occurred in 2004 when it sold Sicor for $3.4B.
Join Mergr to view Ferrer Freeman’s full profile and discover more middle-market private equity firms just like it.
Ferrer Freeman & Co. (FFC) is a private equity firm that invests exclusively in healthcare companies generating sales minimum $20 to $200 million. FFC also invests in clinical products and outsourcing/infrastructure businesses serving the healthcare sector. FFC looks to commit $10 to $40 million per transaction and focuses primarily on growth capital financings and build-ups. However, the Firm will also selectively fund buyouts as well. Ferrer Freeman & Co. LLC was formed in 1995 and is based in Greenwich, Connecticut.
Join Mergr to view the latest updates and news from Greenwich-based Ferrer Freeman.
We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.
Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.
Try us for 1 week free today!
No obligation. Cancel anytime.